The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events-Reference-Cited by-同舟云学术

The impact of CGRPergic monoclonal antibodies on prophylactic antimigraine therapy and potential adverse events

Published:2021-10-04 Issue: Volume: Page:1-13
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

González-Hernández Abimael¹^ORCID,Marichal-Cancino Bruno A.²^ORCID,Villalón Carlos M.³^ORCID

Affiliation:

1. Departamento de Neurobiología del Desarrollo y Neurofisiología, Instituto de Neurobiología, Universidad Nacional Autónoma de México, Querétaro, México

2. Departamento de Fisiología y Farmacología, Universidad Autónoma de Aguascalientes, Ciudad Universitaria, Aguascalientes, México

3. Departamento de Farmacobiología, Cinvestav‑Coapa, Ciudad de México, México

Funder

Consejo Nacional de Ciencia y Tecnología

SEP-Cinvestav Research Support Fund

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2021.1982892

Reference155 articles.

1. Migraine — Current Understanding and Treatment

2. Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition

3. The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments

4. The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs

5. Cost of disorders of the brain in Europe

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CASE HISTORY: NURTEC® ODT (RIMEGEPANT) FOR THE ACUTE AND PREVENTIVE TREATMENT OF MIGRAINE;2022 Medicinal Chemistry Reviews;2022-12-21

2. Gender effect on migraine: nature or culture?;Journal of Integrative Neuroscience;2022-01-28